Volver a Agenda
Session Chair(s)
Nancy Bradish Myers, JD
CEO and Founder
Catalyst Healthcare Consulting, United States
Learning Objective : Identify the ways in which 3D printing could change medical product development; Define the regulatory challenges associated with 3D printing, and potential approaches by regulators; Identify ways in which 3D printing may impact your organization.
Speaker(s)
Scientific Policy on 3D Printers
Steven K. Pollack
Carbon 3D, Inc. , United States
Research Scientist
Industry Perspective
Eric M. David, JD, MD
Organovo, Inc., United States
Co-Founder and Chief Strategy Officer
Industry Perspective
Brian M. Strem
Allergan, Inc., United States
Director, Business Development
¿Tiene una cuenta?